E 3309
Alternative Names: TKS 1044Latest Information Update: 06 Aug 2007
At a glance
- Originator Nagase ChemteX Corporation
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Helicobacter infections
Most Recent Events
- 06 Aug 2007 Discontinued - Phase-I for Helicobacter infections in European Union (PO)
- 06 Aug 2007 Discontinued - Phase-I for Helicobacter infections in USA (PO)
- 06 Aug 2007 Discontinued - Preclinical for Helicobacter infections in Japan (PO)